Lars Ny (L Ny)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 24

Top Venues

Cancers

Cancer research communications

Acta oncologica (Stockholm, Sweden)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Sahlgrenska universitetssjukhuset

Lunds universitet Medicinska fakulteten (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sahlgrenska universitetssjukhuset Jan 01 2016

Sweden

Head of Department :: Gothia Forum

Sahlgrenska universitetssjukhuset Jan 01 2012 - Dec 31 2015

Sweden

Consultant, Associate Professor :: Oncology

Education History

Lunds universitet Medicinska fakulteten Nov 01 1992 - Jan 31 1996

Sweden

PHD :: Clinical Pharmacology

Publications

Vasu R Sah, Henrik Jespersen, Joakim Karlsson, Lisa M Nilsson, Mattias Bergqvist, Iva Johansson, Ana Carneiro, Hildur Helgadottir, Max Levin, Gustav J Ullenhag, Anders Ståhlberg, Roger Olofsson Bagge, Jonas Andreas Nilsson, Lars Ny
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy. Cancer research communications 3 (5) (2023)
Vasu R Sah, Henrik Jespersen, Joakim Karlsson, Lisa M Nilsson, Mattias Bergqvist, Iva Johansson, Ana Carneiro, Hildur Helgadottir, Max Levin, Gustav J Ullenhag, Anders Ståhlberg, Roger Olofsson Bagge, Jonas Andreas Nilsson, Lars Ny
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy. Cancer research communications 3 (5) (2023)
Vasu R Sah, Henrik Jespersen, Joakim Karlsson, Lisa M Nilsson, Mattias Bergqvist, Iva Johansson, Ana Carneiro, Hildur Helgadottir, Max Levin, Gustav J Ullenhag, Anders Ståhlberg, Roger Olofsson Bagge, Jonas Andreas Nilsson, Lars Ny
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy. Cancer research communications 3 (5) (2023)
Kamuran Inci, Bengt Nilsson, Lars Ny, Ulf Strömberg, Nils Wilking, Stefan Lindskog, Daniel Giglio
Targeted Therapy in the Palliative Setting of Colorectal Cancer-Survival and Medical Costs. Cancers 15 (11) (2023)
Roger Olofsson Bagge, Axel Nelson, Amir Shafazand, Charlotta All-Eriksson, Christian Cahlin, Hakon Blomstrand, Hildur Helgadottir, Jens Folke Kiilgaard, Sara Kinhult, Ingrid Ljuslinder, Jan Mattsson, Magnus Rizell, Malin Sternby Eilard, Gustav J Ullenhag, Jonas Andreas Nilsson, Lars Ny, Per Lindnér
Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Elin M V Forsberg, Rebecca Riise, Sara Saellström, Joakim Karlsson, Samuel Alsén, Valentina Bucher, Akseli E Hemminki, Roger Olofsson Bagge, Lars Ny, Lisa M Nilsson, Henrik Rönnberg, Jonas Andreas Nilsson
Treatment with Anti-HER2 Chimeric Antigen Receptor Tumor-Infiltrating Lymphocytes (CAR-TILs) Is Safe and Associated with Antitumor Efficacy in Mice and Companion Dogs. Cancers 15 (3) (2023)
Vasu R Sah, Henrik Jespersen, Joakim Karlsson, Lisa M Nilsson, Mattias Bergqvist, Iva Johansson, Ana Carneiro, Hildur Helgadottir, Max Levin, Gustav J Ullenhag, Anders Ståhlberg, Roger Olofsson Bagge, Jonas Andreas Nilsson, Lars Ny
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy. Cancer research communications 3 (5) (2023)
Vasu R Sah, Henrik Jespersen, Joakim Karlsson, Lisa M Nilsson, Mattias Bergqvist, Iva Johansson, Ana Carneiro, Hildur Helgadottir, Max Levin, Gustav J Ullenhag, Anders Ståhlberg, Roger Olofsson Bagge, Jonas Andreas Nilsson, Lars Ny
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy. Cancer research communications 3 (5) (2023)
Elin M V Forsberg, Rebecca Riise, Sara Saellström, Joakim Karlsson, Samuel Alsén, Valentina Bucher, Akseli E Hemminki, Roger Olofsson Bagge, Lars Ny, Lisa M Nilsson, Henrik Rönnberg, Jonas Andreas Nilsson
Treatment with Anti-HER2 Chimeric Antigen Receptor Tumor-Infiltrating Lymphocytes (CAR-TILs) Is Safe and Associated with Antitumor Efficacy in Mice and Companion Dogs. Cancers 15 (3) (2023)
Hanna Wesslau, Anders Carlander, Lars Ny, Fredrik Wärnberg, Roger Olofsson Bagge, Ann-Sophie Lindqvist Bagge
Tumor Burden and Health-Related Quality of Life in Patients with Melanoma In-Transit Metastases. Cancers 15 (1) (2022)
Fernanda Costa Svedman, Marie Jalsenius, Vitali Grozman, Mattias Bergqvist, Fabian Söderdahl, Samuel Rotstein, Lars Ny, Suzanne Egyhazi Brage, Hildur Helgadottir
Dynamics of plasma thymidine kinase activity in metastatic melanoma reflects immune checkpoint inhibitor efficacy. Acta oncologica (Stockholm, Sweden) 61 (9) (2022)
Fernanda Costa Svedman, Marie Jalsenius, Veronica Höiom, Vitali Grozman, Mattias Bergqvist, Fabian Söderdahl, Hanna Eriksson, Samuel Rotstein, Lars Ny, Paolo A Ascierto, Suzanne Egyhazi Brage, Hildur Helgadottir
Plasma Thymidine Kinase Activity as a Novel Biomarker in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibitors. Cancers 14 (3) (2022)
Ana M Arance, Luis de la Cruz Merino, Teresa M Petrella, Rahima Jamal, Lars Ny, Ana Carneiro, Alfonso Berrocal, Ivan Marquez-Rodas, Anna Spreafico, Victoria Atkinson, Fernanda Costa Svedman, Andrew Mant, Muhammad A Khattak, Catalin Mihalcioiu, Sekwon Jang, C Lance Cowey, Alan D Smith, Natalyn Hawk, Ke Chen, Scott J Diede, Clemens Krepler, Georgina V Long
Phase II LEAP-004 Study of Lenvatinib Plus Pembrolizumab for Melanoma With Confirmed Progression on a Programmed Cell Death Protein-1 or Programmed Death Ligand 1 Inhibitor Given as Monotherapy or in Combination. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Hanna Wesslau, Anders Carlander, Lars Ny, Fredrik Wärnberg, Roger Olofsson Bagge, Ann-Sophie Lindqvist Bagge
Tumor Burden and Health-Related Quality of Life in Patients with Melanoma In-Transit Metastases. Cancers 15 (1) (2022)
Evalyn E A P Mulder, Iva Johansson, Dirk J van Grünhagen, Dennie Tempel, Barbara Rentroia-Pacheco, Jvalini T Dwarkasing, Daniëlle Verver, Antien L Mooyaart, Astrid A M van der Veldt, Marlies Wakkee, Tamar E C Nijsten, Cornelis Verhoef, Jan Mattsson, Lars Ny, Loes M Hollestein, Roger Olofsson Bagge
Using a Clinicopathologic and Gene Expression (CP-GEP) Model to Identify Stage I-II Melanoma Patients at Risk of Disease Relapse. Cancers 14 (12) (2022)
Ellen Backlund, Muyi Yang, Vitali Grozman, Giuseppe V Masucci, Johan Falkenius, Hanna Eriksson, Braslav Jovanovic, Katarina Hammarlund, Ulf Isacsson, Calin Radu, Edvard Abel, Kristin Karlsson, Ricardo Palanco Zamora, Peter Wersäll, Ulrika Edbäck, Stina Linnea Wickström, Eva Darai Ramqvist, Suzanne Egyhazi Brage, Rolf Kiessling, Kristina Viktorsson, Bo Franzén, Rolf Lewensohn, Roger Olofsson Bagge, Gustav J Ullenhag, Lars Ny, Karin Lindberg, Hildur Helgadottir
Precision radiation of immune checkpoint therapy resistant melanoma metastases (PROMMEL study): study protocol for a phase II open-label multicenter trial. Acta oncologica (Stockholm, Sweden) 61 (7) (2022)
Hanna Wesslau, Anders Carlander, Lars Ny, Fredrik Wärnberg, Roger Olofsson Bagge, Ann-Sophie Lindqvist Bagge
Tumor Burden and Health-Related Quality of Life in Patients with Melanoma In-Transit Metastases. Cancers 15 (1) (2022)
Lisa Bondeson, Anna Thulin, Lars Ny, Max Levin, Johanna Svensson, Magnus Lindh, Zhiyuan Zhao
Clinical outcomes in cancer patients with COVID-19 in Sweden. Acta oncologica (Stockholm, Sweden) 60 (12) (2021)
I Johansson, M Levin, L M Akyürek, R Olofsson Bagge, Lars Ny
PD-1 inhibitor therapy of basal cell carcinoma with pulmonary metastasis. Journal of the European Academy of Dermatology and Venereology : JEADV (2021)
Carl-Jacob Holmberg, Dimitrios Katsarelias, Henrik Jespersen, Ana Carneiro, Nils O Elander, Hildur Helgadottir, Karolin Isaksson, Malin Jansson, Sara Wirén, Gustav J Ullenhag, Lars Ny, Roger Olofsson Bagge
Surgery of metastatic melanoma after systemic therapy - the SUMMIST trial: study protocol for a randomized controlled trial. Acta oncologica (Stockholm, Sweden) 60 (1) (2020)
Caroline Robert, Georgina V Long, Benjamin Brady, Caroline Dutriaux, Anna Maria Di Giacomo, Laurent Mortier, Piotr Rutkowski, Jessica C Hassel, Catriona M McNeil, Ewa Anna Kalinka, Celeste Lebbè, Julie Charles, Micaela M Hernberg, Kerry Joane Savage, Vanna Chiarion Sileni, Catalin Mihalcioiu, Cornelia Mauch, Ana Arance, Francesco Cognetti, Lars Ny, Henrik Schmidt, Dirk Schadendorf, Helen J Gogas, Jesús Zoco, Sandra Re, Paolo Antonio Ascierto, Victoria Atkinson
Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (33) (2020)
Dimitrios Katsarelias, Hanna Eriksson, Rasmus Mikiver, Isabelle Krakowski, Jonas Andreas Nilsson, Lars Ny, Roger Olofsson Bagge
The Effect of Beta-Adrenergic Blocking Agents in Cutaneous Melanoma-A Nation-Wide Swedish Population-Based Retrospective Register Study. Cancers 12 (11) (2020)
Dimitrios Katsarelias, Hanna Eriksson, Rasmus Mikiver, Isabelle Krakowski, Jonas Andreas Nilsson, Lars Ny, Roger Olofsson Bagge
Reply to Comment on Katsarelias, D., et al. "The Effect of Beta-Adrenergic Blocking Agents in Cutaneous Melanoma-A Nation-Wide Swedish Population-Based Retrospective Register Study." Cancers 2020, 12, 3228. Cancers 13 (1) (2020)
Henrik Jespersen, Roger Olofsson Bagge, Gustav Ullenhag, Ana Carneiro, Hildur Helgadottir, Ingrid Ljuslinder, Max Levin, Charlotta All-Eriksson, Bengt Andersson, Ulrika Stierner, Lisa M Nilsson, Jonas A Nilsson, Lars Ny
Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study. BMC cancer 19 (1) (2019)

Lars Ny.css-eqlu8i{font-size:small;padding-left:4px;} (L Ny)

Publication Activity (10 Years)

Top Topics

Top Venues

Lars Ny (L Ny)